MaxCyte, Inc.
MXCTHealthcare|Biotechnology|US
$1.26
-0.05 (-3.82%)
Tangible Book / Share
$1.48
Cash / Share
$0.99
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT03608618 Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma | Peritoneal Mesothelioma, Fallopian Tube Adenocarcinoma | P1 | Terminated | 14 | Open-label | MCY-M11, Cyclophosphamide |